Cardio-Oncology

My Settings
Relevant Content
Anthracycline Cardiotoxicity as Multicellular Network Failure: Cardiac Niche Reprogramming and Pathological Cell–Cell Communication
Journal of the American Heart Association, Ahead of Print.
Anthracycl...
Radiation Vasculopathy of the Coronary Arteries: State-of-the Art Review
Circulation, Volume 154, Issue 16, Page 1627-1645, October 20, 2026.
...
Letter by Khouri et al Regarding Article, “CXCR6+ T Cells Drive Immune Checkpoint Inhibitor Myocarditis”
Circulation, Volume 154, Issue 15, Page e589-e590, October 13, 2026.
Permissive Cardiotoxicity: An Evolving Paradigm
Journal of the American Heart Association, Ahead of Print.
Permissive...
An Elusive Cardiac Mass in a Patient With Previous Malignancy
Circulation, Volume 154, Issue 14, Page 1412-1416, October 6, 2026.
Science News from #EPI|Lifestyle25
Exclusive interviews from keynote speakers, presenters and award-winning c...
Proteomics Profiling Reveals Molecular Subtypes of Transthyretin Cardiac Amyloidosis
Circulation: Heart Failure, Ahead of Print.
BACKGROUND:Transthyretin...
Inhibition of Programmed Cell Death-1 in Cytotoxic CD8+ T Cells Exacerbates Pressure Overload–Induced Cardiac Injury
Circulation, Ahead of Print.
BACKGROUND:The use of anti–programmed ce...
Immune Checkpoint Inhibitor Myocarditis and Myotoxicity
Circulation, Volume 154, Issue 9, Page 863-871, September 1, 2026.
Im...
Effect of Anselamimab on Cardiac Structure and Function in Patients With Light Chain Amyloidosis: Insights From the CARES Clinical Trials
Circulation, Ahead of Print.